[
  {
    "date": "2023-12-30",
    "symbol": "MCRB",
    "period": "FY",
    "netincomeloss": -113724000,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "MCRB",
    "entityregistrantname": "Seres Therapeutics, Inc.",
    "entitycentralindexkey": 1609809,
    "entitycurrentreportingstatus": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityshellcompany": "false",
    "entityfilenumber": "001-37465",
    "entitytaxidentificationnumber": "27-4326290",
    "entityaddressaddressline1": "101 Cambridgepark Drive",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2140,
    "cityareacode": 617,
    "localphonenumber": "945-9626",
    "entityincorporationstatecountrycode": "DE",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common stock, par value $0.001 per share",
    "securityexchangename": "NASDAQ",
    "auditorfirmid": 238,
    "auditorname": "PricewaterhouseCoopers LLP",
    "auditorlocation": "Boston, Massachusetts",
    "cashandcashequivalentsatcarryingvalue": 127965000,
    "collaborationreceivablerelatedparty": 8674000,
    "inventorynet": 29647000,
    "prepaidexpenseandotherassetscurrent": 9124000,
    "assetscurrent": 175410000,
    "propertyplantandequipmentnet": 22457000,
    "operatingleaserightofuseasset": 109793000,
    "restrictedcashnoncurrent": 8185000,
    "restrictedinvestmentsnoncurrent": 1401000,
    "otherassetsnoncurrent": 41354000,
    "assets": 358600000,
    "accountspayablecurrent": 3641000,
    "accruedliabilitiesandotherliabilitiescurrent": 80611000,
    "operatingleaseliabilitycurrent": 6677000,
    "deferredincome": 7730000,
    "liabilitiescurrent": 98659000,
    "longtermnotespayable": 101544000,
    "operatingleaseliabilitynoncurrent": 105715000,
    "contractwithcustomerliabilitynoncurrentrelatedparty": 95364000,
    "derivativeliabilitiesnoncurrent": 546000,
    "otherliabilitiesnoncurrent": 1628000,
    "liabilities": 403456000,
    "commonstockvalue": 135000,
    "additionalpaidincapitalcommonstock": 933244000,
    "retainedearningsaccumulateddeficit": -978235000,
    "stockholdersequity": -44856000,
    "liabilitiesandstockholdersequity": 358600000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 240000000,
    "commonstocksharesissued": 135041467,
    "commonstocksharesoutstanding": 135041467,
    "prepaymentsonlongtermcontract": 38877000,
    "otherliabilitiescurrent": 28053000,
    "collaborationrevenuefromrelatedparty": 126325000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2023#LicenseAndServiceMember",
    "revenues": 126325000,
    "researchanddevelopmentexpense": 145860000,
    "generalandadministrativeexpense": 87744000,
    "profitlossfromresearchagreementsrelatedparty": 704000,
    "operatingexpenses": 234308000,
    "operatingincomeloss": -107983000,
    "investmentincomeinterest": 7301000,
    "interestexpensedebt": 13176000,
    "othernonoperatingincomeexpense": 134000,
    "nonoperatingincomeexpense": -5741000,
    "earningspersharebasic": -0.89,
    "earningspersharediluted": -0.89,
    "weightedaveragenumberofsharesoutstandingbasic": 128003294,
    "weightedaveragenumberofdilutedsharesoutstanding": 128003294,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 10000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 2000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": 12000,
    "comprehensiveincomenetoftax": -113712000,
    "stockissuedduringperiodvaluestockoptionsexercised": 877000,
    "stockissuedduringperiodsharesstockoptionsexercised": 260640,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 2000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 602692,
    "restrictedstockvaluesharesissuednetoftaxwithholdings": 1000,
    "restrictedstocksharesissuednetofsharesfortaxwithholdings": 1244663,
    "stockissuedduringperiodsharesnewissues": 7711199,
    "stockissuedduringperiodvalueatmarketequityofferings": 7000,
    "stockissuedduringperiodsharesatmarketequityofferings": 7711199,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 2785000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 34101000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentbeforereclassificationadjustmentsnetoftax": 12000,
    "paymentsofstockissuancecosts": 772000,
    "sharebasedcompensation": 34101000,
    "depreciationdepletionandamortization": 6243000,
    "noncashoperatingleasecost": 8871000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 236000,
    "amortizationoffinancingcosts": 1139000,
    "gainslossesonextinguishmentofdebt": -1625000,
    "fairvalueadjustmentofwarrants": -1554000,
    "collaborationprofitlossrelatedtoprelaunchactivities": -5158000,
    "increasedecreaseinprepaidexpensesandothercurrentandlongtermassets": -29124000,
    "increasedecreaseinaccountsreceivablerelatedparties": 8674000,
    "increasedecreaseininventories": 29647000,
    "increasedecreaseindeferedincomerelatedparty": 7730000,
    "increasedecreaseincontractwithcustomerliabilityrelatedparty": -1325000,
    "increasedecreaseinaccountspayable": -11578000,
    "increasedecreaseinoperatingleaseliabilities": -2197000,
    "increasedecreaseinaccruedexpensesandothercurrentandlongtermliabilities": 15838000,
    "netcashprovidedbyusedinoperatingactivities": -117354000,
    "paymentstoacquirepropertyplantandequipment": 7975000,
    "paymentstoacquireinvestments": 4426000,
    "proceedsfromsalematurityandcollectionsofinvestments": 22983000,
    "netcashprovidedbyusedininvestingactivities": 10582000,
    "proceedsfromissuanceofcommonstock": 18159000,
    "proceedsfromissuanceofcommonstockfromatthemarketequityoffering": 18159000,
    "proceedsfromstockoptionsexercised": 877000,
    "proceedsfromstockplans": 2151000,
    "proceedsfromissuanceofdebt": 103378000,
    "repaymentsofnotespayable": 52860000,
    "netcashprovidedbyusedinfinancingactivities": 71705000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -35067000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 2000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 136150000,
    "interestpaidnet": 12547000,
    "capitalexpendituresincurredbutnotyetpaid": 16000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 3046000,
    "prepaidrentreclassifiedtorightofuseassets": 4634000,
    "nonfinancialliabilitiesforwarrantsrecognised": 2100000,
    "warrantsissuedrelatedtotermloanandrecordedasdebtdiscount": 2785000,
    "accruedexpensesandothercurrentandlongtermliabilitiesrelatedpartyamounts": -6717000,
    "entityincorporationmonthandyearofincorporation": "2010-10",
    "cashequivalentsoriginalmaturitymaximumperiod": "P90D",
    "minimumpercentageoflikelihoodoftaxbenefitbeingrealizeduponsettlement": 0.5,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentusefullifedescriptionoftermextensibleenumeration": "http://fasb.org/us-gaap/2023#UsefulLifeTermOfLeaseMember",
    "liabilitiesfairvaluedisclosure": 546000,
    "cashandcashequivalentsfairvaluedisclosure": 81000,
    "assetsfairvaluedisclosure": 81000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 546000,
    "derivativeliabilityexpectedvolatility": 1.01,
    "derivativeliabilityexpectedterm": "P1Y3M18D",
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilityissues": 2100000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": -1554000,
    "fairvaluerecurringbasisunobservableinputreconciliationliabilitygainlossstatementofincomeextensiblelist": "http://fasb.org/us-gaap/2023#NonoperatingIncomeExpense",
    "inventoryrawmaterials": 4426000,
    "inventoryworkinprocess": 25221000,
    "otherresearchanddevelopmentexpense": 26794000,
    "propertyplantandequipmentgross": 29081000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 51138000,
    "disposaloffullydepreciatedassetscostbasis": 145000,
    "accruedclinicalanddevelopmentcostscurrent": 1404000,
    "manufacturingandqualitycosts": 31917000,
    "employeerelatedliabilitiescurrent": 16465000,
    "collaborationpayablerelatedparty": 28053000,
    "otheraccruedliabilitiescurrent": 2772000,
    "accruedexpense": 30049000,
    "restructuringreservecurrent": 5080000,
    "lesseeoperatingleaseremainingtermofcontract": "P1Y",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseoptiontoextend": "Certain leases include one or more options to renew, exercisable at the Company’s sole discretion, with renewal terms that can extend the lease from approximately one year to ten years.",
    "lesseeoperatingleaserenewalterm": "P1Y",
    "operatingleaseliability": 1235000,
    "paymentstoacquireleasereceivables": 10400000,
    "leaseholdimprovementsgross": 2336000,
    "operatingleasepayments": 15656000,
    "operatingleaseweightedaverageremainingleaseterm1": "P7Y11M12D",
    "operatingleaseweightedaveragediscountratepercent": 0.13,
    "operatingleasecost": 22324000,
    "shorttermleasecost": 1477000,
    "variableleasecost": 7229000,
    "leasecost": 31030000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 19869000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 22062000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 22674000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 23347000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 23580000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 65819000,
    "lesseeoperatingleaseliabilitypaymentsdue": 177351000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 64959000,
    "debtinstrumentbasisspreadonvariablerate1": 0.064,
    "lineofcreditfacilityinterestrateduringperiod": 0.0965,
    "debtinstrumentcarryingamount": 50586000,
    "debtinstrumentinterestrateeffectivepercentage": 0.159,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.072,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0364,
    "derivativefairvalueofderivativeliability": 276000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 24750000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 33000000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfive": 33000000,
    "longtermdebtmaturitiesrepaymentsofprincipalafteryearfive": 19250000,
    "longtermdebt": 110000000,
    "averageshareprice": 2.46,
    "percentageofcommissiononsaleofcommonstock": 3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsterm": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "The exercise prices, vesting and other restrictions are determined at the discretion of the board of directors, or their committee if so delegated, except that the exercise price per share of stock options may not be less than 100% of the fair market value of the share of common stock on the date of grant and the term of stock option may not be greater than ten years. The Company generally granted stock-based awards with service conditions only (“service-based” awards).",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 2545586,
    "deferredcompensationarrangementwithindividualcommonstockreservedforfutureissuance": 2266512,
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 0.15,
    "offeringperiodundertheplan": "P6M",
    "percentageofpurchasepricewithrespecttoeachofferingperiod": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 14844112,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2508553,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 2343835,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 14844112,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 10488694,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 9.64,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 5.44,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 3.36,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 8.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 9.64,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 10.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P5Y8M15D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P5Y7M28D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P4Y7M9D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 4.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 438000,
    "allocatedsharebasedcompensationexpense": 2051000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 3377804,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 4424479,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 1071571,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 1524644,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 4.26,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 4.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 6.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 7.22,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluevested": 4729000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "employeebenefitsandsharebasedcompensation": 815000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardplanmodificationincrementalcompensationcost": 261000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 35036000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y1M6D",
    "milestonespaymentsreceived": 125000000,
    "transactionpriceallocatedundercollaborativearrangement": 10064000,
    "contractwithcustomerliability": 95364000,
    "maximumdevelopmentmilestonepaymentstobereceived": 285000000,
    "maximumregulatorypaymentstobereceived": 375000000,
    "maximumamounttobereceivedonachievementofcertaincommercialmilestones": 1125000000,
    "revenueremainingperformanceobligation": 200000000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 1975000,
    "deferredrevenuefromrelatedparty": 95364000,
    "contractwithcustomerliabilitywithrelatedparty": 95364000,
    "contractwithcustomerliabilityadditionswithrelatedparties": 1644000,
    "contractwithcustomerliabilityrevenuerecognizedwithrelatedparty": -2969000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 14844112,
    "investmenttypeextensibleenumeration": "http://fasb.org/us-gaap/2023#WarrantMember",
    "restructuringcharges": 5606000,
    "deferredcompensationarrangementwithindividualallocatedsharebasedcompensationexpense": 261000,
    "paymentsforrestructuring": 265000,
    "collaborationarrangementcostassociatedwithprelaunchactivities": 1446000,
    "shareofrelatedpartynetloss": -18873000,
    "profitontransferofrelatedpartyinventory": 23327000,
    "profitlossfromresearchagreementrelatedparty": -704000,
    "paymentsonlongtermcontract": 12276000,
    "prepaidexpensenoncurrent": 30049000,
    "operatinglosscarryforwards": 527065000,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentcosts": 102558000,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentperformanceperiod": "P5Y",
    "operatinglosscarryforwardsexpirationyear": 2035,
    "netoperatinglossesontaxableincomethresholdpercentage": 0.8,
    "taxcreditcarryforwardamount": 53928000,
    "taxcreditcarryforwardexpirationyear": 2031,
    "unrecognizedtaxbenefits": 13529000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.043,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.078,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.014,
    "effectiveincometaxratereconciliationuncertaintaxpositionreserves": 0.008,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.003,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.312,
    "deferredtaxassetsoperatinglosscarryforwards": 142506000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 52843000,
    "deferredtaxassetsdeferredexpensecapitalizedresearchanddevelopmentcosts": 55572000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 25898000,
    "deferredtaxassetsleaseliability": 29855000,
    "deferredtaxassetsdeferredincome": 27452000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 3540000,
    "deferredtaxassetssection163jlimitationcaresact": 3741000,
    "deferredtaxassetspropertyplantandequipment": 398000,
    "deferredtaxassetsother": 169000,
    "deferredtaxassetsgross": 341974000,
    "deferredtaxliabilitiesrightofuseassets": 29165000,
    "deferredincometaxliabilities": 29165000,
    "deferredtaxassetsvaluationallowance": 312809000,
    "increaseinvaluationallowancedeferredtaxasset": 35439000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 1001000,
    "sellinggeneralandadministrativeexpense": 37387000,
    "paymentforcollaborationreceivable": 31243000,
    "otherreceivablesnetcurrent": 8674000,
    "lesseetermofoperatingsubleasedescription": "The term of the sublease agreement commenced in July 2019 and ended in November 2021",
    "subleasecommencementdate": "2019-07",
    "definedcontributionplancostrecognized": 2003000
  },
  {
    "date": "2022-12-31",
    "symbol": "MCRB",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2022-12-31",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "MCRB",
    "entityregistrantname": "Seres Therapeutics, Inc.",
    "entitycentralindexkey": 1609809,
    "entitycurrentreportingstatus": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "entityfilenumber": "001-37465",
    "entitytaxidentificationnumber": "27-4326290",
    "entityaddressaddressline1": "200 Sidney Street – 4th Floor",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 617,
    "localphonenumber": "945-9626",
    "entityincorporationstatecountrycode": "DE",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common stock, par value $0.001 per share",
    "securityexchangename": "NASDAQ",
    "auditorfirmid": 238,
    "auditorname": "PricewaterhouseCoopers LLP",
    "auditorlocation": "Boston, Massachusetts",
    "cashandcashequivalentsatcarryingvalue": 163030000,
    "shortterminvestments": 18311000,
    "prepaidexpenseandotherassetscurrent": 13423000,
    "assetscurrent": 194764000,
    "propertyplantandequipmentnet": 22985000,
    "operatingleaserightofuseasset": 110984000,
    "restrictedcashnoncurrent": 8185000,
    "restrictedinvestmentsnoncurrent": 1401000,
    "otherassetsnoncurrent": 10465000,
    "assets": 348784000,
    "accountspayablecurrent": 17440000,
    "accruedliabilitiesandotherliabilitiescurrent": 59840000,
    "operatingleaseliabilitycurrent": 3601000,
    "notespayablecurrent": 456000,
    "contractwithcustomerliabilitycurrentrelatedparty": 4259000,
    "liabilitiescurrent": 85596000,
    "longtermnotespayable": 50591000,
    "operatingleaseliabilitynoncurrent": 107942000,
    "contractwithcustomerliabilitynoncurrentrelatedparty": 92430000,
    "otherliabilitiesnoncurrent": 1442000,
    "liabilities": 338001000,
    "commonstockvalue": 125000,
    "additionalpaidincapitalcommonstock": 875181000,
    "accumulatedothercomprehensiveincomelossnetoftax": -12000,
    "retainedearningsaccumulateddeficit": -864511000,
    "stockholdersequity": 10783000,
    "liabilitiesandstockholdersequity": 348784000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 125222273,
    "commonstocksharesoutstanding": 125222273,
    "duetorelatedpartiescurrent": 34770000,
    "duetorelatedpartiesnoncurrent": 833000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 7128000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2022#LicenseAndServiceMember",
    "revenues": 7128000,
    "researchanddevelopmentexpense": 172920000,
    "generalandadministrativeexpense": 79694000,
    "profitlossfromresearchagreementsrelatedparty": 1004000,
    "operatingexpenses": 253618000,
    "operatingincomeloss": -246490000,
    "investmentincomeinterest": 3058000,
    "interestexpensedebt": 6020000,
    "othernonoperatingincomeexpense": -705000,
    "nonoperatingincomeexpense": -3667000,
    "netincomeloss": -250157000,
    "earningspersharebasic": -2.31,
    "earningspersharediluted": -2.31,
    "weightedaveragenumberofsharesoutstandingbasic": 108077043,
    "weightedaveragenumberofdilutedsharesoutstanding": 108077043,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 49000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -1000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": 48000,
    "comprehensiveincomenetoftax": -250109000,
    "stockissuedduringperiodvaluenewissues": 32000,
    "stockissuedduringperiodsharesnewissues": 31746030,
    "stockissuedduringperiodvalueatmarketequityofferings": 1000,
    "stockissuedduringperiodsharesatmarketequityofferings": 655000,
    "stockissuedduringperiodvaluestockoptionsexercised": 966000,
    "stockissuedduringperiodsharesstockoptionsexercised": 326864,
    "restrictedstocksharesissuednetofsharesfortaxwithholdings": 282401,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 1769000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 322560,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 25482000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentbeforereclassificationadjustmentsnetoftax": 48000,
    "paymentsofstockissuancecosts": 3279000,
    "sharebasedcompensation": 25482000,
    "depreciationdepletionandamortization": 6629000,
    "noncashoperatingleasecost": 5224000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -688000,
    "amortizationoffinancingcosts": 705000,
    "profitlossfromresearchagreementrelatedparty": -1004000,
    "increasedecreaseinprepaidexpensesandothercurrentandlongtermassets": -12599000,
    "increasedecreaseincontractwithcustomerliabilityrelatedparty": -7128000,
    "increasedecreaseinaccountspayable": 2203000,
    "increasedecreaseinoperatingleaseliabilities": -4203000,
    "increasedecreaseinaccruedexpensesandothercurrentandlongtermliabilities": 3336000,
    "netcashprovidedbyusedinoperatingactivities": -228816000,
    "paymentstoacquirepropertyplantandequipment": 9821000,
    "paymentstoacquireinvestments": 48221000,
    "proceedsfromsalematurityandcollectionsofinvestments": 140470000,
    "netcashprovidedbyusedininvestingactivities": 82428000,
    "proceedsfromissuanceofcommonstock": 96721000,
    "proceedsfromissuanceoflongtermdebt": 27606000,
    "proceedsfromatthemarketequityofferingnetofcommissions": 4447000,
    "proceedsfromstockoptionsexercised": 966000,
    "proceedsfromstockplans": 1769000,
    "repaymentsofnotespayable": 1907000,
    "netcashprovidedbyusedinfinancingactivities": 129602000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -16786000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": -1000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 171215000,
    "interestpaidnet": 4926000,
    "capitalexpendituresincurredbutnotyetpaid": 2276000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 91412000,
    "prepaidrentreclassifiedtorightofuseassets": 6822000,
    "accruedexpensesandothercurrentandlongtermliabilitiesrelatedpartyamounts": 3087000,
    "entityincorporationmonthandyearofincorporation": "2010-10",
    "cashcashequivalentsandshortandlongterminvestments": 181341000,
    "milestonespayments": 125000000,
    "lineofcreditfacilitycurrentborrowingcapacity": 25000000,
    "cashequivalentsoriginalmaturitymaximumperiod": "P90D",
    "minimumpercentageoflikelihoodoftaxbenefitbeingrealizeduponsettlement": 0.5,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentestimatedusefullives": "Lesser of useful lifeor lease term",
    "cashandcashequivalentsfairvaluedisclosure": 47863000,
    "availableforsalesecuritiesdebtsecurities": 2465000,
    "assetsfairvaluedisclosure": 47863000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 2465000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 3000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 1000,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearamortizedcost": 18321000,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearfairvalue": 18311000,
    "propertyplantandequipmentgross": 24533000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 45040000,
    "disposaloffullydepreciatedassetscostbasis": 1857000,
    "accrueddevelopmentandclinicalmanufacturingcostscurrent": 6717000,
    "employeerelatedliabilitiescurrent": 14709000,
    "accruedliabilityrelatedto2021licenseagreementcurrent": 34770000,
    "otheraccruedliabilitiescurrent": 3644000,
    "lesseeoperatingleaseremainingtermofcontract": "P2Y",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseoptiontoextend": "Certain leases include one or more options to renew, exercisable at the Company’s sole discretion, with renewal terms that can extend the lease from approximately one year to five years.",
    "lesseeoperatingleaserenewalterm": "P1Y",
    "operatingleaseliability": 111543000,
    "operatingleasepayments": 7809000,
    "assetretirementobligation": 452000,
    "operatingleaseweightedaverageremainingleaseterm1": "P8Y11M1D",
    "operatingleaseweightedaveragediscountratepercent": 0.13,
    "operatingleasecost": 8830000,
    "shorttermleasecost": 1375000,
    "variableleasecost": 4547000,
    "leasecost": 14752000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 16815000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 19055000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 21164000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 21755000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfour": 108383000,
    "lesseeoperatingleaseliabilitypaymentsdue": 187172000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 75629000,
    "debtinstrumentbasisspreadonvariablerate1": 0.064,
    "lineofcreditfacilityinterestrateduringperiod": 0.0965,
    "lineofcreditfacilityfrequencyofpaymentandpaymentterms": "Following an interest-only period of 24 months, principal payments are due in 24 equal monthly installments commencing December 1, 2021 and ending November 1, 2023",
    "notespayableprincipalpaymentsequalmonthlyinstallments": 24,
    "debtinstrumentcarryingamount": 50586000,
    "debtinstrumentinterestrateeffectivepercentage": 0.1501,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 50000000,
    "longtermdebt": 50000000,
    "shareprice": 7.26,
    "percentageofcommissiononsaleofcommonstock": 3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsterm": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "The exercise prices, vesting and other restrictions are determined at the discretion of the board of directors, or their committee if so delegated, except that the exercise price per share of stock options may not be less than 100% of the fair market value of the share of common stock on the date of grant and the term of stock option may not be greater than ten years. The Company generally granted stock-based awards with service conditions only (“service-based” awards).",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 967206,
    "deferredcompensationarrangementwithindividualcommonstockreservedforfutureissuance": 2469204,
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 0.15,
    "offeringperiodundertheplan": "P6M",
    "percentageofpurchasepricewithrespecttoeachofferingperiod": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0167,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.04,
    "allocatedsharebasedcompensationexpense": 13429000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 14940034,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 4527897,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 778188,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 7441253,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 10.03,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 6.89,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.96,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 10.62,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 10.38,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y3M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y10M17D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 11608000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 8115000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.53,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 981000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1549540,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 1302844,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 205658,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 282401,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 9.37,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 6.95,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 11.82,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 18.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluevested": 1809000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "employeebenefitsandsharebasedcompensation": 815000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 57005000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y9M18D",
    "transactionpriceallocatedundercollaborativearrangement": 34770000,
    "collaborationarrangementcostassociatedwithprelaunchactivities": 6102000,
    "contractwithcustomerliability": 1976000,
    "maximumdevelopmentmilestonepaymentstobereceived": 285000000,
    "maximumregulatorypaymentstobereceived": 375000000,
    "maximumamounttobereceivedonachievementofcertaincommercialmilestones": 1125000000,
    "revenueremainingperformanceobligation": 200000000,
    "deferredrevenuefromrelatedparty": 96689000,
    "researchanddevelopmentfixedconsideration": 20000000,
    "researchanddevelopmentestimatedreimbursementcosts": 13900000,
    "contractwithcustomerliabilitywithrelatedparty": 96689000,
    "contractwithcustomerliabilityrevenuerecognizedwithrelatedparty": -7128000,
    "netincomelossavailabletocommonstockholdersbasic": -250157000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 14940034,
    "paymentsonlongtermcontract": 12276000,
    "operatinglosscarryforwards": 501789000,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentcosts": 160586000,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentperformanceperiod": "P5Y",
    "operatinglosscarryforwardsexpirationyear": 2035,
    "netoperatinglossesontaxableincomethresholdpercentage": 0.8,
    "taxcreditcarryforwardamount": 50248000,
    "taxcreditcarryforwardexpirationyear": 2031,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.031,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.043,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.006,
    "effectiveincometaxratereconciliationuncertaintaxpositionreserves": 0.046,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": -0.003,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.229,
    "deferredtaxassetsoperatinglosscarryforwards": 132560000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 48854000,
    "deferredtaxassetsdeferredexpensecapitalizedresearchanddevelopmentcosts": 38894000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 20048000,
    "deferredtaxassetsleaseliability": 29717000,
    "deferredtaxassetsdeferredincome": 29922000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 4044000,
    "deferredtaxassetssection163jlimitationcaresact": 2303000,
    "deferredtaxassetspropertyplantandequipment": 396000,
    "deferredtaxassetsother": 200000,
    "deferredtaxassetsgross": 306938000,
    "deferredtaxliabilitiesrightofuseassets": 29568000,
    "deferredincometaxliabilities": 29568000,
    "deferredtaxassetsvaluationallowance": 277370000,
    "increaseinvaluationallowancedeferredtaxasset": 57256000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 12528000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 12528000,
    "lesseetermofoperatingsubleasedescription": "The term of the sublease agreement commenced in July 2019 and ended in November 2021",
    "definedcontributionplancostrecognized": 1921000
  },
  {
    "date": "2021-12-31",
    "symbol": "MCRB",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2021-12-31",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "MCRB",
    "entityregistrantname": "Seres Therapeutics, Inc.",
    "entitycentralindexkey": 1609809,
    "entitycurrentreportingstatus": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "entityfilenumber": "001-37465",
    "entitytaxidentificationnumber": "27-4326290",
    "entityaddressaddressline1": "200 Sidney Street – 4th Floor",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 617,
    "localphonenumber": "945-9626",
    "entityincorporationstatecountrycode": "DE",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common stock, par value $0.001 per share",
    "securityexchangename": "NASDAQ",
    "auditorfirmid": 238,
    "auditorname": "PricewaterhouseCoopers LLP",
    "auditorlocation": "Boston, Massachusetts",
    "cashandcashequivalentsatcarryingvalue": 180002000,
    "shortterminvestments": 110704000,
    "prepaidexpenseandotherassetscurrent": 12922000,
    "assetscurrent": 303628000,
    "propertyplantandequipmentnet": 17938000,
    "operatingleaserightofuseasset": 18208000,
    "restrictedcashnoncurrent": 8000000,
    "restrictedinvestmentsnoncurrent": 1401000,
    "longterminvestments": 495000,
    "otherassetsnoncurrent": 5189000,
    "assets": 354859000,
    "accountspayablecurrent": 13735000,
    "accruedliabilitiesandotherliabilitiescurrent": 45094000,
    "operatingleaseliabilitycurrent": 6610000,
    "contractwithcustomerliabilitycurrentrelatedparty": 16819000,
    "liabilitiescurrent": 82258000,
    "longtermnotespayable": 24643000,
    "operatingleaseliabilitynoncurrent": 17958000,
    "contractwithcustomerliabilitynoncurrentrelatedparty": 86998000,
    "otherliabilitiesnoncurrent": 11495000,
    "liabilities": 223352000,
    "commonstockvalue": 92000,
    "additionalpaidincapitalcommonstock": 745829000,
    "accumulatedothercomprehensiveincomelossnetoftax": -60000,
    "retainedearningsaccumulateddeficit": -614354000,
    "stockholdersequity": 131507000,
    "liabilitiesandstockholdersequity": 354859000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 91889418,
    "commonstocksharesoutstanding": 91889418,
    "duetorelatedpartiescurrent": 21098000,
    "duetorelatedpartiesnoncurrent": 10585000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 143857000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2021-01-31#LicenseAndServiceMember",
    "revenuefromgrant": 1070000,
    "revenues": 144927000,
    "researchanddevelopmentexpense": 141891000,
    "generalandadministrativeexpense": 69261000,
    "profitlossfromresearchagreementrelatedparty": 1732000,
    "operatingexpenses": 209420000,
    "operatingincomeloss": -64493000,
    "investmentincomeinterest": 2870000,
    "interestexpensedebt": 2910000,
    "othernonoperatingincomeexpense": -1045000,
    "nonoperatingincomeexpense": -1085000,
    "netincomeloss": -65578000,
    "earningspersharebasicanddiluted": -0.72,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 91702866,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -12000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -1000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": -13000,
    "comprehensiveincomenetoftax": -65591000,
    "stockissuedduringperiodvaluestockoptionsexercised": 1000,
    "stockissuedduringperiodsharesstockoptionsexercised": 329112,
    "restrictedstocksharesissuednetofsharesfortaxwithholdings": 650,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 827000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 100417,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 20222000,
    "sharebasedcompensation": 20222000,
    "depreciationdepletionandamortization": 5947000,
    "noncashoperatingleasecost": 3275000,
    "amortizationoffinancingcosts": 498000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -2526000,
    "increasedecreaseinprepaidexpensesandothercurrentandlongtermassets": -12337000,
    "increasedecreaseinaccountsreceivable": -9387000,
    "increasedecreaseincontractwithcustomerliability": -4357000,
    "increasedecreaseinaccountspayable": 9362000,
    "increasedecreaseinoperatingleaseliabilities": -3550000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 43025000,
    "netcashprovidedbyusedinoperatingactivities": 6688000,
    "paymentstoacquirepropertyplantandequipment": 9566000,
    "paymentstoacquireinvestments": 95971000,
    "proceedsfromsalematurityandcollectionsofinvestments": 169625000,
    "netcashprovidedbyusedininvestingactivities": 64088000,
    "proceedsfromstockoptionsexercised": 1299000,
    "proceedsfromstockplans": 827000,
    "repaymentsofnotespayable": 948000,
    "netcashprovidedbyusedinfinancingactivities": 1178000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 71954000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": -1000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 188002000,
    "interestpaidnet": 2446000,
    "capitalexpendituresincurredbutnotyetpaid": 874000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 12442000,
    "accruedexpensesandothercurrentandlongtermliabilitiesrelatedpartyamounts": 31683000,
    "entityincorporationmonthandyearofincorporation": "2010-10",
    "cashcashequivalentsandshortandlongterminvestments": 291201000,
    "cashequivalentsoriginalmaturitymaximumperiod": "P90D",
    "propertyplantandequipmentusefullife": "P5Y",
    "minimumpercentageoflikelihoodoftaxbenefitbeingrealizeduponsettlement": 0.5,
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "2020-01-01",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "cashandcashequivalentsfairvaluedisclosure": 70322000,
    "availableforsalesecuritiesdebtsecurities": 6250000,
    "assetsfairvaluedisclosure": 70322000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 6250000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 28000,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearamortizedcost": 110762000,
    "availableforsalesecuritiesdebtmaturitiesafteronethroughfiveyearsamortizedcost": 496000,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearfairvalue": 110704000,
    "availableforsalesecuritiesdebtmaturitiesafteronethroughfiveyearsfairvalue": 495000,
    "propertyplantandequipmentgross": 19137000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 40268000,
    "accrueddevelopmentandclinicalmanufacturingcostscurrent": 11147000,
    "employeerelatedliabilitiescurrent": 9216000,
    "accruedliabilityrelatedto2021licenseagreementcurrent": 21098000,
    "otheraccruedliabilitiescurrent": 3633000,
    "lesseeoperatingleaseremainingtermofcontract": "P1Y",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseoptiontoextend": "Certain leases include one or more options to renew, exercised at the Company’s sole discretion, with renewal terms that can extend the lease from one year to five years.",
    "lesseeoperatingleaserenewalterm": "P1Y",
    "lesseeoperatingsubleaseexistenceofoptiontoextend": "false",
    "lesseeoperatingsubleaseoptiontoextend": "The term of the sublease agreement commenced in July 2019 and ends on the last day of the 24th calendar month following commencement, with no option to extend.",
    "subleasecommencementdate": "2019-07",
    "operatingleasepayments": 6821000,
    "operatingleaseweightedaverageremainingleaseterm1": "P6Y1M13D",
    "operatingleaseweightedaveragediscountratepercent": 0.1,
    "operatingleaseliability": 24568000,
    "operatingleasecost": 5170000,
    "shorttermleasecost": 1452000,
    "variableleasecost": 3300000,
    "subleaseincome": 1575000,
    "leasecost": 8347000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 8512000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 7480000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 2392000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 2466000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfour": 10891000,
    "lesseeoperatingleaseliabilitypaymentsdue": 31741000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 7173000,
    "lineofcreditfacilityfrequencyofpaymentandpaymentterms": "Following an interest-only period of 24 months, principal payments are due in 24 equal monthly installments commencing December 1, 2021 and ending November 1, 2023",
    "notespayableinterestonlyperiod": "P24M",
    "notespayableprincipalpaymentsequalmonthlyinstallments": 24,
    "debtinstrumentcarryingamount": 24643000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 24051000,
    "longtermdebt": 24051000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsterm": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "The exercise prices, vesting and other restrictions are determined at the discretion of the board of directors, or their committee if so delegated, except that the exercise price per share of stock options may not be less than 100% of the fair market value of the share of common stock on the date of grant and the term of stock option may not be greater than ten years. The Company generally granted stock-based awards with service conditions only (“service-based” awards).",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 2138525,
    "deferredcompensationarrangementwithindividualcommonstockreservedforfutureissuance": 2391764,
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 0.15,
    "offeringperiodundertheplan": "P6M",
    "percentageofpurchasepricewithrespecttoeachofferingperiod": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.012,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P0Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.749,
    "allocatedsharebasedcompensationexpense": 530000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 11517189,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 3603744,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 1794573,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 5590163,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 11.1,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 19.3,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 3.84,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 12.19,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 8.62,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y5M1D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y1M2D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 28006768000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 16670723000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 15.33,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 4727000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 734755,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 768998,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 40093,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 650,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 17.68,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 17.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 23.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 25.36,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluevested": 16000,
    "numberofemployeesgranted": 2,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 57913000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P3Y3M29D",
    "transactionpriceallocatedundercollaborativearrangement": 21098000,
    "collaborationarrangementcostassociatedwithprelaunchactivities": 2168000,
    "contractwithcustomerliability": 6089000,
    "maximumdevelopmentmilestonepaymentstobereceived": 285000000,
    "maximumregulatorypaymentstobereceived": 375000000,
    "maximumamounttobereceivedonachievementofcertaincommercialmilestones": 1125000000,
    "revenueremainingperformanceobligation": 200000000,
    "deferredrevenuefromrelatedparty": 103817000,
    "optionexerciseperiodfromexclusivityperiod": "P90D",
    "researchanddevelopmentfixedconsideration": 20000000,
    "researchanddevelopmentestimatedreimbursementcosts": 13900000,
    "contractwithcustomerliabilitywithrelatedparty": 103817000,
    "contractwithcustomerliabilitywithrelatedpartyadditions": 8157000,
    "contractwithcustomerliabilityrevenuerecognizedwithrelatedparty": -12514000,
    "netincomelossavailabletocommonstockholdersbasic": -65578000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 11517189,
    "operatinglosscarryforwards": 402500000,
    "operatinglosscarryforwardsexpirationyear": 2035,
    "netoperatinglossesontaxableincomethresholdpercentage": 0.8,
    "taxcreditcarryforwardamount": 43700000,
    "taxcreditcarryforwardexpirationyear": 2031,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.166,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.028,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.004,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": -0.004,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.404,
    "deferredtaxassetsoperatinglosscarryforwards": 108189000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 53133000,
    "deferredtaxassetscapitalizedorganizationcosts": 181000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 16045000,
    "deferredtaxassetsleaseliability": 6635000,
    "deferredtaxassetscharitablecontributioncarryforwards": 50000,
    "deferredtaxassetsdeferredincome": 36666000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 2475000,
    "deferredtaxassetsdeferredexpensecapitalizedresearchanddevelopmentcosts": 43000,
    "deferredtaxassetssection163jlimitationcaresact": 1368000,
    "deferredtaxassetspropertyplantandequipment": 247000,
    "deferredtaxassetsgross": 225032000,
    "deferredtaxliabilitiesrightofuseassets": 4918000,
    "deferredincometaxliabilities": 4918000,
    "deferredtaxassetsvaluationallowance": 220114000,
    "increaseinvaluationallowancedeferredtaxasset": 26378000,
    "lesseetermofoperatingsubleasedescription": "The term of the sublease agreement commenced in July 2019 and ends on the last day of the 24th calendar month following commencement, with no option to extend",
    "relatedpartytransactionotherrevenuesfromtransactionswithrelatedparty": 1575000,
    "definedcontributionplancostrecognized": 1087000
  },
  {
    "date": "2020-12-31",
    "symbol": "MCRB",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": " MCRB",
    "entityregistrantname": "Seres Therapeutics, Inc.",
    "entitycentralindexkey": 1609809,
    "entitycurrentreportingstatus": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "entityfilenumber": "001-37465",
    "entitytaxidentificationnumber": "27-4326290",
    "entityaddressaddressline1": "200 Sidney Street – 4th Floor",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 617,
    "localphonenumber": "945-9626",
    "entityincorporationstatecountrycode": "DE",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common stock, par value $0.001 per share",
    "securityexchangename": "NASDAQ",
    "cashandcashequivalentsatcarryingvalue": 116049000,
    "shortterminvestments": 137567000,
    "prepaidexpenseandotherassetscurrent": 5774000,
    "accountsreceivablenetcurrent": 9387000,
    "assetscurrent": 268777000,
    "propertyplantandequipmentnet": 13897000,
    "operatingleaserightofuseasset": 9041000,
    "restrictedinvestmentsnoncurrent": 1400000,
    "longterminvestments": 49825000,
    "assets": 342940000,
    "accountspayablecurrent": 4018000,
    "accruedliabilitiesandotherliabilitiescurrent": 14226000,
    "operatingleaseliabilitycurrent": 5115000,
    "notespayablecurrent": 454000,
    "contractwithcustomerliabilitycurrentrelatedparty": 22602000,
    "liabilitiescurrent": 46415000,
    "longtermnotespayable": 24639000,
    "operatingleaseliabilitynoncurrent": 10561000,
    "contractwithcustomerliabilitynoncurrentrelatedparty": 85572000,
    "otherliabilitiesnoncurrent": 1003000,
    "liabilities": 168190000,
    "commonstockvalue": 91000,
    "additionalpaidincapitalcommonstock": 723482000,
    "accumulatedothercomprehensiveincomelossnetoftax": -47000,
    "retainedearningsaccumulateddeficit": -548776000,
    "stockholdersequity": 174750000,
    "liabilitiesandstockholdersequity": 342940000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 91459239,
    "commonstocksharesoutstanding": 91459239,
    "revenuefromcontractwithcustomerexcludingassessedtax": 11897000,
    "typeofrevenueextensiblelist": "us-gaap:LicenseAndServiceMember",
    "revenuefromgrant": 4157000,
    "revenuefromresearchagreement": 17161000,
    "revenues": 33215000,
    "researchanddevelopmentexpense": 90570000,
    "generalandadministrativeexpense": 30775000,
    "operatingexpenses": 121345000,
    "operatingincomeloss": -88130000,
    "investmentincomeinterest": 946000,
    "interestexpensedebt": 2924000,
    "othernonoperatingincome": 981000,
    "nonoperatingincomeexpense": -997000,
    "netincomeloss": -89127000,
    "earningspersharebasicanddiluted": -1.12,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 79789220,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -47000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": -47000,
    "comprehensiveincomenetoftax": -89174000,
    "stockissuedduringperiodvaluenewissues": 12000,
    "stockissuedduringperiodsharesnewissues": 12075000,
    "stockissuedduringperiodtorelatedpartyvalue": 1000,
    "stockissuedduringperiodtorelatedpartyshares": 959002,
    "stockissuedduringperiodvalueatmarketequityoffering": 6000,
    "stockissuedduringperiodsharesatmarketequityoffering": 5787681,
    "stockissuedduringperiodvaluestockoptionsexercised": 2000,
    "stockissuedduringperiodsharesstockoptionsexercised": 2214011,
    "restrictedstockvaluesharesissuednetoftaxwithholdings": 120000,
    "restrictedstocksharesissuednetofsharesfortaxwithholdings": 125000,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 462000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 155293,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 8824000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentbeforereclassificationadjustmentsnetoftax": -47000,
    "sharebasedcompensation": 8824000,
    "depreciationdepletionandamortization": 6578000,
    "noncashoperatingleasecost": 2315000,
    "amortizationoffinancingcosts": 446000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -551000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 2186000,
    "increasedecreaseinaccountsreceivable": 7602000,
    "increasedecreaseincontractwithcustomerliability": -11565000,
    "increasedecreaseinaccountspayable": -1159000,
    "increasedecreaseinoperatingleaseliabilities": -4456000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 3771000,
    "netcashprovidedbyusedinoperatingactivities": -93610000,
    "paymentstoacquirepropertyplantandequipment": 591000,
    "paymentstoacquireinvestments": 218284000,
    "proceedsfromsalematurityandcollectionsofinvestments": 59984000,
    "netcashprovidedbyusedininvestingactivities": -158891000,
    "proceedsfromissuanceofcommonstock": 243748000,
    "proceedsfromsecuritiespurchaseagreementnetofissuancecostsrelatedparty": 19900000,
    "proceedsfromatthemarketequityofferingnetofcommissions": 24773000,
    "proceedsfromstockoptionsexercised": 14421000,
    "proceedsfromissuanceofcommonstockandrestrictedcommonstock": 120000,
    "proceedsfromstockplans": 462000,
    "netcashprovidedbyusedinfinancingactivities": 303424000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 50923000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 116049000,
    "interestpaidnet": 2453000,
    "capitalexpendituresincurredbutnotyetpaid": 451000,
    "entityincorporationmonthandyearofincorporation": "2010-10",
    "shareprice": 4.4,
    "cashcashequivalentsandshortandlongterminvestments": 303441000,
    "cashequivalentsoriginalmaturitymaximumperiod": "P90D",
    "propertyplantandequipmentusefullife": "P5Y",
    "billedcontractreceivables": 1186000,
    "unbilledcontractsreceivable": 8201000,
    "minimumpercentageoflikelihoodoftaxbenefitbeingrealizeduponsettlement": 0.5,
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "2019-01-01",
    "changeinaccountingprincipleaccountingstandardsupdatetransitionoptionelectedextensiblelist": "us-gaap:AccountingStandardsUpdate201602RetrospectiveMember",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "cashandcashequivalentsfairvaluedisclosure": 35480000,
    "availableforsalesecuritiesdebtsecurities": 12343000,
    "assetsfairvaluedisclosure": 35480000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 12343000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 8000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 52000,
    "availableforsalesecuritiesdebtmaturitiesafteronethroughfiveyearsfairvalue": 49825000,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearamortizedcost": 137588000,
    "availableforsalesecuritiesdebtmaturitiesafteronethroughfiveyearsamortizedcost": 49851000,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearfairvalue": 137567000,
    "propertyplantandequipmentgross": 15985000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 34320000,
    "accrueddevelopmentandclinicalmanufacturingcostscurrent": 6339000,
    "employeerelatedliabilitiescurrent": 6734000,
    "otheraccruedliabilitiescurrent": 1153000,
    "lesseeoperatingleaseremainingtermofcontract": "P1Y",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseoptiontoextend": "Certain leases include one or more options to renew, exercised at the Company’s sole discretion, with renewal terms that can extend the lease from one year to five years.",
    "lesseeoperatingleaserenewalterm": "P1Y",
    "lesseeoperatingsubleaseexistenceofoptiontoextend": "false",
    "lesseeoperatingsubleaseoptiontoextend": "The term of the sublease agreement commenced in July 2019 and ends on the last day of the 24th calendar month following commencement, with no option to extend.",
    "operatingleasepayments": 6302000,
    "operatingleaseweightedaverageremainingleaseterm1": "P2Y10M20D",
    "operatingleaseweightedaveragediscountratepercent": 0.11,
    "lesseeoperatingsubleasepaymentstobereceivednexttwelvemonths": 633000,
    "lesseeoperatingsubleasepaymentstobereceived": 633000,
    "operatingleaseliability": 15676000,
    "operatingleasecost": 4163000,
    "shorttermleasecost": 1457000,
    "variableleasecost": 2890000,
    "subleaseincome": 1813000,
    "leasecost": 6697000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 6461000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 6390000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 5158000,
    "lesseeoperatingleaseliabilitypaymentsdue": 18009000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 2333000,
    "paymentsforrestructuring": 193000,
    "lineofcreditfacilityfrequencyofpaymentandpaymentterms": "The Company will make interest only payments through December 1, 2021. The interest only period may be extended to June 1, 2022 upon satisfaction of certain milestones. Following the interest only period, the Company will repay the principal balance and interest of the advances in equal monthly installments through November 1, 2023.",
    "debtinstrumentcarryingamount": 25093000,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 949000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 11970000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 12081000,
    "longtermdebt": 25000000,
    "percentageofcommissiononsaleofcommonstock": 3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsterm": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "The exercise prices, vesting and other restrictions are determined at the discretion of the board of directors, or their committee if so delegated, except that the exercise price per share of stock options may not be less than 100% of the fair market value of the share of common stock on the date of grant and the term of stock option may not be greater than ten years. The Company generally granted stock-based awards with service conditions only (“service-based” awards).",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1018232,
    "deferredcompensationarrangementwithindividualcommonstockreservedforfutureissuance": 2092181,
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 0.15,
    "offeringperiodundertheplan": "P6M",
    "percentageofpurchasepricewithrespecttoeachofferingperiod": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.012,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.749,
    "allocatedsharebasedcompensationexpense": 200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 10037130,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 5095365,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 1154907,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 3164129,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 9.54,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 7.11,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 6.51,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 10.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 14.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y10M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y9M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 156627000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 34652000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 37255000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 6500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 6500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 5000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 125000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 25.36,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 25.36,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 9.12,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 2.29,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluevested": 532000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 26221000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P3Y5M26D",
    "contractwithcustomerliability": 108174000,
    "maximumdevelopmentmilestonepaymentstobereceived": 285000000,
    "maximumregulatorypaymentstobereceived": 375000000,
    "maximumamounttobereceivedonachievementofcertaincommercialmilestones": 1125000000,
    "proceedsfromcollaborators": 10000000,
    "collaborativearrangementupfrontlicensefeereceived": 120000000,
    "revenueremainingperformanceobligation": 200000000,
    "revenueinformationusedtodeterminetransactionprice": "The Company estimated the $20,000 of variable consideration by using the most likely amount method which best predicts the amount of consideration to which the Company will be entitled.",
    "contractwithcustomerassetcumulativecatchupadjustmenttorevenuechangeinmeasureofprogress": 4565000,
    "deferredrevenuefromrelatedparty": 108174000,
    "optionexerciseperiodfromexclusivityperiod": "P90D",
    "termsofdefinitivelicenseagreementgoodfaithnegotiationperiod": "P6M",
    "othertermsofdefinitivelicenseagreementperiod": "P1Y",
    "researchanddevelopmentfixedconsideration": 20000000,
    "researchanddevelopmentestimatedreimbursementcosts": 13900000,
    "researchanddevelopmentreimbursementcostsincurred": 3376000,
    "contractwithcustomerliabilitywithrelatedparty": 108174000,
    "contractwithcustomerliabilitywithrelatedpartyadditions": 10000000,
    "contractwithcustomerliabilityrevenuerecognizedwithrelatedparty": -11897000,
    "contractwithcustomerliabilityadditions": 7493000,
    "contractwithcustomerliabilityrevenuerecognized": -17161000,
    "netincomelossavailabletocommonstockholdersbasic": -89127000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 10037130,
    "operatinglosscarryforwards": 390000000,
    "operatinglosscarryforwardsexpirationyear": 2035,
    "netoperatinglossesontaxableincomethresholdpercentage": 1,
    "taxcreditcarryforwardamount": 36400000,
    "taxcreditcarryforwardexpirationyear": 2031,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.064,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.078,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.058,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": -0.002,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.408,
    "deferredtaxassetsoperatinglosscarryforwards": 106351000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 42311000,
    "deferredtaxassetscapitalizedorganizationcosts": 214000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 11615000,
    "deferredtaxassetsleaseliability": 4283000,
    "deferredtaxassetscharitablecontributioncarryforwards": 15000,
    "deferredtaxassetsdeferredincome": 29553000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 1783000,
    "deferredtaxassetsdeferredexpensecapitalizedresearchanddevelopmentcosts": 51000,
    "deferredtaxassetssection163jlimitationcaresact": 540000,
    "deferredtaxassetsgross": 196716000,
    "deferredtaxliabilitiespropertyplantandequipment": 510000,
    "deferredtaxliabilitiesrightofuseassets": 2470000,
    "deferredincometaxliabilities": 2980000,
    "deferredtaxassetsvaluationallowance": 193736000,
    "increaseinvaluationallowancedeferredtaxasset": 36390000,
    "subleasecommencementdate": "2019-07",
    "relatedpartytransactionotherrevenuesfromtransactionswithrelatedparty": 1813000,
    "definedcontributionplancostrecognized": 586000
  },
  {
    "date": "2019-12-30",
    "symbol": "MCRB",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "MCRB",
    "entityregistrantname": "Seres Therapeutics, Inc.",
    "entitycentralindexkey": 1609809,
    "entitycurrentreportingstatus": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "entityshellcompany": "false",
    "entityfilenumber": "001-37465",
    "entitytaxidentificationnumber": "27-4326290",
    "entityaddressaddressline1": "200 Sidney Street – 4th Floor",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 617,
    "localphonenumber": "945-9626",
    "entityincorporationstatecountrycode": "DE",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common stock, par value $0.001 per share",
    "securityexchangename": "NASDAQ",
    "cashandcashequivalentsatcarryingvalue": 65126000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 29690000,
    "prepaidexpenseandotherassetscurrent": 3588000,
    "accountsreceivablenetcurrent": 1785000,
    "assetscurrent": 100189000,
    "propertyplantandequipmentnet": 19495000,
    "operatingleaserightofuseasset": 11356000,
    "restrictedinvestmentsnoncurrent": 1400000,
    "assets": 132440000,
    "accountspayablecurrent": 4859000,
    "accruedliabilitiesandotherliabilitiescurrent": 10884000,
    "operatingleaseliabilitycurrent": 4456000,
    "contractwithcustomerliabilitycurrentrelatedparty": 20960000,
    "contractwithcustomerliabilitycurrent": 4834000,
    "liabilitiescurrent": 45993000,
    "longtermnotespayable": 24648000,
    "operatingleaseliabilitynoncurrent": 15676000,
    "contractwithcustomerliabilitynoncurrentrelatedparty": 89111000,
    "contractwithcustomerliabilitynoncurrent": 4834000,
    "otherliabilitiesnoncurrent": 502000,
    "liabilities": 180764000,
    "commonstockvalue": 70000,
    "additionalpaidincapitalcommonstock": 411255000,
    "retainedearningsaccumulateddeficit": -459649000,
    "stockholdersequity": -459649000,
    "liabilitiesandstockholdersequity": 132440000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 70143252,
    "commonstocksharesoutstanding": 70143252,
    "revenuefromcontractwithcustomerexcludingassessedtax": 27188000,
    "typeofrevenueextensiblelist": "us-gaap:LicenseAndServiceMember",
    "revenuefromgrant": 1102000,
    "revenuefromresearchagreement": 6215000,
    "revenues": 34505000,
    "researchanddevelopmentexpense": 80141000,
    "generalandadministrativeexpense": 24748000,
    "restructuringcharges": 1492000,
    "operatingexpenses": 106381000,
    "operatingincomeloss": -71876000,
    "investmentincomeinterest": 1033000,
    "interestexpensedebt": 502000,
    "othernonoperatingincome": 1066000,
    "nonoperatingincomeexpense": 1597000,
    "netincomeloss": -70279000,
    "earningspersharebasicanddiluted": -1.24,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 56649220,
    "comprehensiveincomenetoftax": -70279000,
    "stockissuedduringperiodvaluenewissues": 60527000,
    "stockissuedduringperiodsharesnewissues": 128400,
    "stockissuedduringperiodvalueatmarketequityoffering": 512000,
    "stockissuedduringperiodsharesatmarketequityoffering": 128400,
    "stockissuedduringperiodvaluestockoptionsexercised": 145000,
    "stockissuedduringperiodsharesstockoptionsexercised": 90125,
    "restrictedstockvaluesharesissuednetoftaxwithholdings": 176000,
    "restrictedstocksharesissuednetofsharesfortaxwithholdings": 94400,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 296000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 108346,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 8344000,
    "sharebasedcompensation": 8344000,
    "depreciationdepletionandamortization": 7603000,
    "noncashoperatingleasecost": 2227000,
    "noncashinterestexpense": 281000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 172000,
    "gainlossondispositionofassets": -103000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -3257000,
    "increasedecreaseinaccountsreceivable": 1785000,
    "increasedecreaseincontractwithcustomerliability": -17520000,
    "increasedecreaseinaccountspayable": -1460000,
    "increasedecreaseinoperatingleaseliabilities": -4211000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": -2908000,
    "netcashprovidedbyusedinoperatingactivities": -76520000,
    "paymentstoacquirepropertyplantandequipment": 1002000,
    "paymentstoacquireinvestments": 46420000,
    "proceedsfromsalematurityandcollectionsofinvestments": 16904000,
    "netcashprovidedbyusedininvestingactivities": -30518000,
    "proceedsfromissuanceofcommonstock": 60527000,
    "proceedsfromissuanceoflongtermdebt": 25000000,
    "proceedsfromatthemarketequityoffering": 512000,
    "paymentsofdebtissuancecosts": 425000,
    "proceedsfromstockoptionsexercised": 145000,
    "proceedsfromissuanceofcommonstockandrestrictedcommonstock": 176000,
    "proceedsfromstockplans": 296000,
    "netcashprovidedbyusedinfinancingactivities": 86231000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -20807000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 65126000,
    "interestpaidnet": 221000,
    "capitalexpendituresincurredbutnotyetpaid": 62000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 154000,
    "entityincorporationdateofincorporation": "2010-10-31",
    "cashcashequivalentsandshortterminvestments": 94816000,
    "cashequivalentsoriginalmaturitymaximumperiod": "P90D",
    "propertyplantandequipmentusefullife": "P3Y",
    "collaborativearrangementupfrontlicensefeereceived": 120000000,
    "periodofperformanceidentifiabledeliverables": "P10Y",
    "minimumpercentageoflikelihoodoftaxbenefitbeingrealizeduponsettlement": 0.5,
    "cashandcashequivalentsfairvaluedisclosure": 4900000,
    "availableforsalesecuritiesdebtsecurities": 29690000,
    "assetsfairvaluedisclosure": 64343000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 29689000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 3000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 2000,
    "propertyplantandequipmentgross": 47237000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 27742000,
    "accrueddevelopmentandclinicalmanufacturingcostscurrent": 5605000,
    "employeerelatedliabilitiescurrent": 4609000,
    "otheraccruedliabilitiescurrent": 670000,
    "operatingleaseliability": 20132000,
    "lesseeoperatingleaseremainingtermofcontract": "P5Y",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseoptiontoextend": "Certain leases include one or more options to renew, exercised at the Company’s sole discretion, with renewal terms that can extend the lease from one year to five years.",
    "lesseeoperatingleaserenewalterm": "P5Y",
    "lesseeoperatingsubleaseexistenceofoptiontoextend": "false",
    "lesseeoperatingsubleaseoptiontoextend": "The term of the sublease agreement commenced in July 2019 and ends on the last day of the 24th calendar month following commencement, with no option to extend",
    "leaseandrentalexpense": 4322000,
    "operatingleasepayments": 6514000,
    "operatingleaseweightedaverageremainingleaseterm1": "P3Y10M17D",
    "operatingleaseweightedaveragediscountratepercent": 0.11,
    "lesseeoperatingsubleasepaymentstobereceivednexttwelvemonths": 1248000,
    "lesseeoperatingsubleasepaymentstobereceivedyeartwo": 633000,
    "lesseeoperatingsubleasepaymentstobereceived": 1881000,
    "operatingleasecost": 4532000,
    "shorttermleasecost": 1878000,
    "variableleasecost": 3022000,
    "subleaseincome": 890000,
    "leasecost": 8542000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 6302000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 6461000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 6390000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 5157000,
    "lesseeoperatingleaseliabilitypaymentsdue": 24310000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 4178000,
    "paymentsforrestructuring": 1299000,
    "restructuringreservecurrent": 193000,
    "debtinstrumentcarryingamount": 24648000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 949000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 11970000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 12081000,
    "longtermdebt": 25000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsterm": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "The exercise prices, vesting and other restrictions are determined at the discretion of the board of directors, or their committee if so delegated, except that the exercise price per share of stock options may not be less than 100% of the fair market value of the share of common stock on the date of grant and the term of stock option may not be greater than ten years. The Company generally granted stock-based awards with service conditions only (“service-based” awards).",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 2154460,
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 0.15,
    "offeringperiodundertheplan": "P6M",
    "percentageofpurchasepricewithrespecttoeachofferingperiod": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0264,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.884,
    "allocatedsharebasedcompensationexpense": 8344000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 8310683,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 1617761,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 8310683,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4815001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 10.36,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 5.79,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.61,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 12.82,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 10.36,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 12.47,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y3D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y3D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y9M10D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 3427000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 3427000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 3296000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 4.58,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 244000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 130000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 20000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 22500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 94400,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 8.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.69,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 8.77,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 9.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluevested": 517000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 9387000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y3M18D",
    "contractwithcustomerliability": 110071000,
    "maximumdevelopmentmilestonepaymentstobereceived": 285000000,
    "maximumregulatorypaymentstobereceived": 375000000,
    "maximumamounttobereceivedonachievementofcertaincommercialmilestones": 1125000000,
    "revenueremainingperformanceobligation": 33900000,
    "revenueinformationusedtodeterminetransactionprice": "The Company estimated the $20,000 of variable consideration by using the most likely amount method which best predicts the amount of consideration to which the Company will be entitled.",
    "deferredrevenuefromrelatedparty": 110071000,
    "optionexerciseperiodfromexclusivityperiod": "P90D",
    "termsofdefinitivelicenseagreementgoodfaithnegotiationperiod": "P6M",
    "othertermsofdefinitivelicenseagreementperiod": "P1Y",
    "researchanddevelopmentfixedconsideration": 20000000,
    "researchanddevelopmentestimatedreimbursementcosts": 13900000,
    "contractwithcustomerliabilitywithrelatedparty": 110071000,
    "contractwithcustomerliabilityrevenuerecognizedwithrelatedparty": 27188000,
    "contractwithcustomerliabilityadditions": 15883000,
    "contractwithcustomerliabilityrevenuerecognized": 6215000,
    "netincomelossavailabletocommonstockholdersbasic": -70279000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 8530504,
    "operatinglosscarryforwards": 265671000,
    "operatinglosscarryforwardsexpirationyear": 2035,
    "netoperatinglossesontaxableincomethresholdpercentage": 0.8,
    "taxcreditcarryforwardamount": 18817000,
    "taxcreditcarryforwardexpirationyear": 2028,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.058,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.068,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.017,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.007,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.36,
    "deferredtaxassetsoperatinglosscarryforwards": 72752000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 36602000,
    "deferredtaxassetscapitalizedorganizationcosts": 244000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 12783000,
    "deferredtaxassetsleaseliability": 5500000,
    "deferredtaxassetscharitablecontributioncarryforwards": 13000,
    "deferredtaxassetsdeferredincome": 32713000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 1251000,
    "deferredtaxassetsdeferredexpensecapitalizedresearchanddevelopmentcosts": 58000,
    "deferredtaxassetsgross": 161916000,
    "deferredtaxliabilitiespropertyplantandequipment": 1467000,
    "deferredtaxliabilitiesrightofuseassets": 3103000,
    "deferredincometaxliabilities": 4570000,
    "deferredtaxassetsvaluationallowance": 157346000,
    "increaseinvaluationallowancedeferredtaxasset": 25337000,
    "subleasecommencementdate": "2019-07",
    "relatedpartytransactionotherrevenuesfromtransactionswithrelatedparty": 890000,
    "definedcontributionplancostrecognized": 542000
  }
]